ATAI
Price
$1.31
Change
-$0.16 (-10.81%)
Updated
Apr 3 closing price
Capitalization
260.77M
46 days until earnings call
COUR
Price
$6.34
Change
-$0.41 (-6.07%)
Updated
Apr 3 closing price
Capitalization
2.21B
32 days until earnings call
Ad is loading...

ATAI vs COUR

Header iconATAI vs COUR Comparison
Open Charts ATAI vs COURBanner chart's image
ATAI Life Sciences
Price$1.31
Change-$0.16 (-10.81%)
Volume$1.75M
Capitalization260.77M
Coursera
Price$6.34
Change-$0.41 (-6.07%)
Volume$2.77M
Capitalization2.21B
ATAI vs COUR Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. COUR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and COUR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ATAI: $1.32 vs. COUR: $6.34)
Brand notoriety: ATAI and COUR are both not notable
ATAI represents the Biotechnology, while COUR is part of the Miscellaneous Commercial Services industry
Current volume relative to the 65-day Moving Average: ATAI: 55% vs. COUR: 148%
Market capitalization -- ATAI: $260.77M vs. COUR: $2.21B
ATAI [@Biotechnology] is valued at $260.77M. COUR’s [@Miscellaneous Commercial Services] market capitalization is $2.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The market cap for tickers in the [@Miscellaneous Commercial Services] industry ranges from $80.94B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B. The average market capitalization across the [@Miscellaneous Commercial Services] industry is $5.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCOUR’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • COUR’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than COUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while COUR’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 5 bearish.
  • COUR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ATAI and COUR are a bad buy in the short-term.

Price Growth

ATAI (@Biotechnology) experienced а -16.24% price change this week, while COUR (@Miscellaneous Commercial Services) price change was -8.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was -1.81%. For the same industry, the average monthly price growth was -2.36%, and the average quarterly price growth was +6.67%.

Reported Earning Dates

ATAI is expected to report earnings on May 20, 2025.

COUR is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Miscellaneous Commercial Services (-1.81% weekly)

The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COUR($2.21B) has a higher market cap than ATAI($261M). ATAI YTD gains are higher at: -1.128 vs. COUR (-25.412). ATAI (-124.33M) and COUR (-129.13M) have comparable annual earnings (EBITDA) . COUR has more cash in the bank: 722M vs. ATAI (85.9M). COUR has less debt than ATAI: COUR (6.6M) vs ATAI (23.8M). COUR has higher revenues than ATAI: COUR (636M) vs ATAI (331K).
ATAICOURATAI / COUR
Capitalization261M2.21B12%
EBITDA-124.33M-129.13M96%
Gain YTD-1.128-25.4124%
P/E RatioN/AN/A-
Revenue331K636M0%
Total Cash85.9M722M12%
Total Debt23.8M6.6M361%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICOUR
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
66%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSPPX7.250.03
+0.40%
Invesco SteelPath MLP Alpha Plus R6
JISGX19.80N/A
N/A
JPMorgan Small Cap Growth L
VSIIX45.56N/A
N/A
Vanguard Small Cap Value Index I
HFDYX18.73N/A
N/A
Hartford Schroders US MidCap Opps Y
APITX11.80N/A
N/A
Yorktown Growth L

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-11.15%
MNMD - ATAI
48%
Loosely correlated
-7.04%
CYBN - ATAI
46%
Loosely correlated
-4.79%
COUR - ATAI
45%
Loosely correlated
-6.07%
VCYT - ATAI
45%
Loosely correlated
-5.51%
RXRX - ATAI
44%
Loosely correlated
-9.07%
More

COUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COUR has been loosely correlated with DNB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if COUR jumps, then DNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COUR
1D Price
Change %
COUR100%
-6.07%
DNB - COUR
48%
Loosely correlated
-0.56%
UDMY - COUR
46%
Loosely correlated
-8.86%
ARLO - COUR
46%
Loosely correlated
-11.63%
ATAI - COUR
45%
Loosely correlated
-11.15%
CHGG - COUR
32%
Poorly correlated
-8.68%
More